AKYA — Akoya Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00- $67.94m
- $118.00m
- $81.67m
- 45
- 50
- 17
- 30
Annual cashflow statement for Akoya Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -16.7 | -42.9 | -70.6 | -63.3 | -55.4 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 3.65 | 6.79 | 7.8 | 18.1 | 17.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.39 | -4.56 | 2.16 | -14.5 | -13.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -6.84 | -36.1 | -53.5 | -50.9 | -44.1 |
| Capital Expenditures | -3.29 | -5.09 | -7.36 | -3.65 | -2.46 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 10 | 0 | -6.72 | 7 | -21.6 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 6.73 | -5.09 | -14.1 | 3.35 | -24.1 |
| Financing Cash Flow Items | -4.42 | 137 | -2.35 | -2.04 | -2.27 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 5.49 | 137 | 28.7 | 56.8 | -3.21 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.37 | 95.9 | -38.8 | 9.29 | -71.4 |